Last updated on November 2018

Registry of Patients Treated With Systemic Mold-Active Triazoles


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Invasive Fungal Infection
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients taking one of the following target drugs at the time of enrollment: isavuconazonium sulfate (ISAV), voriconazole (VORI), posaconazole (POSA).

Exclusion Criteria:

  • Currently enrolled in any clinical trial with an investigational antifungal agent. Individuals who subsequently enroll in an investigational antifungal study will be discontinued and data collected up to the time of investigational product will be evaluable.
  • Patients who died before entering the study.
  • Patients who previously participated in this registry.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.